DIN 02455455 — INVOKAMET 150 MG; 1000 MG
INVOKAMET is a tablet of Canagliflozin / Metformin marketed by JANSSEN INC. The full Canagliflozin / Metformin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02455455
- Brand name
- INVOKAMET
- Active ingredient
- Canagliflozin / Metformin
- Strength
- 150 MG; 1000 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- JANSSEN INC
- Health Canada status
- MARKETED
- Drug class
- SGLT2 inhibitor and biguanide combination (antihyperglycemic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Canagliflozin / Metformin products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02455420 | INVOKAMET | 50 MG; 1000 MG | TABLET | JANSSEN INC | MARKETED |
| 02455404 | INVOKAMET | 500 MG; 50 MG | TABLET | JANSSEN INC | MARKETED |